Specialty / Expertise

Melanoma, Renal, and Germ Cell Cancer

Research Interests

Current Research Projects

Research Staff

Training

Dr. Margolin received her MD from Stanford University, Stanford, CA. She completed her Internal Medicine Residency at Yale New Haven Hospital, New Haven, CT. She was a Post-Doctoral Fellow in Hematology/Oncology at University of California, Sand Diego, San Diego, CA. She was a Post-Doctoral Fellow in Hematology and Bone Marrow Transplantation at City of Hope National Medical Center, Duarte, CA.

Selected Publications:

Sosman JA, Carrillo, C, Urba, WJ, Flaherty, L, Atkins, MB, Clark, J, Dutcher, J, Margolin, KA, Mier, J, Gollob, J, Weiss, G, Kirkwood, J, Panka, D, LaFleur, B, Ernstoff, MS, A Cytokine Working Group (CWG) three-arm phase II trial of gp100 (210M)-peptide plus high-dose Interleukin-2 in HLA-A2+ advanced melanoma patients Journal Of Clinical Oncology (in press)

Clark, J; Mehrabi, J, Sosman, J, Logan, T, Margolin, K, Dutcher, J, Urba, Ernstoff, M, McDermott, D, Lau, A, Atkins, M Phase I/II Trial of Outpatient PEG-interferon With Interleukin-2 in Advanced Renal Cell Carcinoma: A Cytokine Working Group Study J Immunother 30: 839-846, 2007

Kavanagh, B, Andrew, K, Venook, A, Margolin, K, Zeh, H, Lotze, M, Schillinger, B, Liu, W, Lu, Y, Mitsky, P, Bercovici, N, Bender, J, Mills, B, Fong, L Vaccination of Metastatic Colorectal Cancer Patients with Matured Dendritic Cells Loaded with Multiple Major Histocompatibility Complex Class 1 Peptides Journal of Immunotherapy, 30: 762-772, 2007

Motzer R, Michaelson D, Rosenberg J, Bukowski R, Curti B, George D, Hudes G, Redman B, Margolin K, Merchan J, Wilding G Sunitinib Efficacy in a Pivotal Trial for Advanced Renal Cell Carcinoma Journal of Urology, 178: 1883-1887, 2007

Margolin K, Synold T, Lara P, Frankel P, Lacey S, Quinn D, Baratta T, Dutcher J, Xi B, Diamond D, Gandara D Oblimersen and α-Interferon in Metastatic Renal Cancer: a Phase II Study of the California Cancer Consortium J Cancer Res and Clin Oncol, 133: 705-711, 2007